Cardiac oxidative stress and histological alterations in asthmatic rats: translational insights from montelukast, prednisolone, and salbutamol therapy
Journal of Phytomedicine and Therapeutics · 2025 · 24 (2)
DOI: 10.4314/jopat.v24i2.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Phytomedicine and Therapeutics, 2025. Verfasst von Ogechukwu Emmanuel Osasogie Aloamaka und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Asthma is a chronic inflammatory condition primarily affecting the airways, but it is increasingly recognized for its systemic effects, especially on the cardiovascular system. Oxidative stress plays a key role in the development of both asthma and cardiovascular disease. This study investigates the cardioprotective potential of montelukast, prednisolone, and salbutamol on oxidative stress markers and myocardial tissue changes in a rat model of ovalbumin-induced asthma. Forty-two female Sprague-Dawley rats were divided into six groups: negative control, asthma-induced (positive control), and four treatment groups receiving salbutamol, montelukast, prednisolone, or a combination of salbutamol and prednisolone. Asthma was induced through ovalbumin sensitization and aerosol challenge for 28 days, followed by four weeks of drug treatment. Heart tissues were collected for biochemical assays of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), as well as for histological analysis using hematoxylin and eosin staining. Data analysis was performed using one-way ANOVA (p < 0.05). Asthma induction significantly increased MDA levels and caused structural damage to the myocardium, including congestion, vasoconstriction, and inflammatory cell infiltration. Salbutamol increased SOD, CAT, and GPx activities but did not lower MDA levels. Montelukast and prednisolone significantly reduced oxidative stress and preserved myocardial structure, notably increasing catalase activity and decreasing lipid peroxidation. The combined salbutamol/prednisolone treatment showed no added benefit over monotherapy. Montelukast and prednisolone offer significant cardioprotective effects by reducing oxidative stress and maintaining myocardial integrity in asthma. Salbutamol enhances antioxidant enzyme activity but does not mitigate oxidative damage. These findings have implications for reducing cardiovascular risk in the management of asthma.
Zitieren
APA
Aloamaka, O. E. O., & Obodo, F. O. (2025). Cardiac oxidative stress and histological alterations in asthmatic rats: translational insights from montelukast, prednisolone, and salbutamol therapy. Journal of Phytomedicine and Therapeutics, 24(2). https://doi.org/10.4314/jopat.v24i2.3
Vancouver
Aloamaka OEO, Obodo FO. Cardiac oxidative stress and histological alterations in asthmatic rats: translational insights from montelukast, prednisolone, and salbutamol therapy. Journal of Phytomedicine and Therapeutics. 2025;24(2). doi:10.4314/jopat.v24i2.3
BibTeX
@article{Aloamaka2025,
author = {Aloamaka, Ogechukwu Emmanuel Osasogie and Obodo, Favour Onyebuchi},
title = {Cardiac oxidative stress and histological alterations in asthmatic rats: translational insights from montelukast, prednisolone, and salbutamol therapy},
journal = {Journal of Phytomedicine and Therapeutics},
year = {2025},
volume = {24},
number = {2},
doi = {10.4314/jopat.v24i2.3}
}
EUVIMED